MedPath

Black Women's Wellness Project

Not Applicable
Completed
Conditions
Weight, Body
Knowledge, Attitudes, Practice
Interventions
Behavioral: PRIDE counseling intervention
Registration Number
NCT04063059
Lead Sponsor
University of Michigan
Brief Summary

The proposed randomized controlled trial will evaluate an educational self-management intervention in 450 African American women and weight management. It will be the first to use a culturally tailored in-person and telephone approach to address all aspects of wellness and social determinants for African American women to achieve optimal long term wellness for both self and family.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
454
Inclusion Criteria
  • Self-identified African American woman, aged 20-59
  • BMI 27.5-57.4
  • Ability to walk unrestricted for > 3 min
  • Caretaker of a child -providing a meal at least 50% of days/week
  • Caretaker of at least one child aged 5 -12 years
  • Resides in Jackson, Saginaw, Ypsilanti, Lansing, Detroit (All cities in Michigan)
  • Speaks English fluently
Read More
Exclusion Criteria
  • <12 months postpartum
  • Active pregnancy
  • Prior or anticipated bariatric surgery
  • Non-ambulatory
  • History of a severe cardiovascular event (including cerebrovascular accident or myocardial infarction)
  • Severe mental illness, neurologic disease and/or cognitive impairment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionPRIDE counseling interventionSubjects will be randomized to the program intervention which is a female-specific, culturally relevant, self-regulation based in-person group sessions and telephone counseling intervention designed for African American women who are overweight or obese.
Primary Outcome Measures
NameTimeMethod
Weight (lb)Closing Event (Month 12)

After 12 months all women will be invited to come to a clinical data collection event "Closing Event" where weight will be collected for all women on the same measurement scale. All measurements will be taken by project staff to ensure data validly.

Secondary Outcome Measures
NameTimeMethod
Height (inches)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where height will be collected for all women on the same stadiometer. All measurements will be taken by project staff to ensure data validly.

Waist Circumference (inches)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where waist circumference will be collected for all women using the same measuring tape. All measurements will be taken by project staff to ensure data validly.

Blood Pressure (mmHg)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where blood pressure will be collected for all women using the same electronic blood pressure machine on their non-dominant arm. All measurements will be taken by project staff to ensure data validly.

Total Cholesterol (mg/dL)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where total cholesterol will be collected for all women using the same CardioCheck PA Analyzer machine. All measurements will be taken by project staff to ensure data validly.

High Density Lipoprotein Cholesterol (mg/dL)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where High Density Lipoprotein Cholesterol will be collected for all women using the same CardioCheck PA Analyzer machine. All measurements will be taken by project staff to ensure data validly.

Low Density Lipoprotein Cholesterol (mg/dL)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where Low Density Lipoprotein Cholesterol will be collected for all women using the same CardioCheck PA Analyzer machine. All measurements will be taken by project staff to ensure data validly.

Triglycerides (mg/dL)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where triglycerides will be collected for all women using the same CardioCheck PA Analyzer machine. All measurements will be taken by project staff to ensure data validly.

Hemoglobin A1cClosing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where Hemoglobin A1c will be collected for all women using the same A1C Now+ machine. All measurements will be taken by project staff to ensure data validly.

Total Distance Walked (ft)Closing Event (Month 12)

All women will be invited to come to a clinical data collection event "Closing Event" where women will walk for 6 minutes and total distance will be measured by the same measuring tape. All measurements will be taken by project staff to ensure data validly.

© Copyright 2025. All Rights Reserved by MedPath